- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05109923
Onnit Labs New Mood Supplementation in Healthy College Students
October 27, 2021 updated by: Ann Brown, University of Idaho
The Effect of Onnit New Mood Supplementation in Healthy Collegiate Men and Women
The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™ dietary supplement in supporting optimal mood balance and reducing daily stress among collegiate-aged men and women.
To be considered for this study, the participant must meet the following criteria: (1) current undergraduate student at the University of Idaho between 18-24 years of age, (2) have no known allergies to the ingredients of New Mood™ (Niacin, Vitamin B6, Magnesium, Valerian Extract, Lemon Balm Extract, L-Tryptophan.
5-Hydroxytryptophan, and Inositol) or the placebo (rice bran and maltodextrin), (3) not currently taking any mood/sleep supplementation or medications, (4) not currently seeking therapy or diagnosed with a psychological disorder, (5) not regularly using cigarettes, marijuana, or other illicit drugs, and (6) not pregnant or breastfeeding.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Idaho
-
Moscow, Idaho, United States, 83844
- University of Idaho
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 24 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Currently enrolled collegiate men and women at the University of Idaho
Exclusion Criteria:
- Currently taking mood or sleep enhancing supplementation/medication
- Currently participating in counseling and/or therapy sessions
- Previously diagnosed with a psychological disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: New Mood Supplementation
The New Mood herbal supplement includes lemon balm, 5-HPT, L-Tryptophan and valerian root.
|
Weeks 0-2 all participants consumed a placebo lead-in period and weeks 2-6 were intervention weeks.
Throughout the 8 weeks (2 weeks placebo lead-in and 6 weeks intervention) participants were asked to consume 2 capsules (multi-ingredient supplement) upon waking in the morning and 2 capsules (multi-ingredient supplement) before bed.
|
|
Placebo Comparator: Placebo Supplementation
The placebo includes rice bran and maltodextrin.
|
Weeks 0-8 all participants consumed a placebo.
Throughout the 8 weeks participants were asked to consume 2 capsules (placebo) upon waking in the morning and 2 capsules (placebo) before bed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in cortisol awakening response (mg/dL) over 8 weeks
Time Frame: Change from baseline cortisol awakening response (mg/dL) at 8 weeks
|
Three salivary cortisol measurements to determine cortisol awakening response (mg/dL) from baseline to 8 weeks
|
Change from baseline cortisol awakening response (mg/dL) at 8 weeks
|
|
Change in resting heart rate (beats per minute) over 8 weeks
Time Frame: Change from baseline resting heart rate (beats per minute) response at 8 weeks
|
Manual radial pulse measurement of resting heart rate (beats per minute) at baseline and 8 weeks
|
Change from baseline resting heart rate (beats per minute) response at 8 weeks
|
|
Change in resting systolic and diastolic blood pressure (mm Hg) over 8 weeks
Time Frame: Change from baseline resting systolic and diastolic blood pressure (mm Hg) at 8 weeks
|
Digital sphygmomanometer measurement of resting systolic and diastolic blood pressure (mm Hg) at baseline and 8 weeks
|
Change from baseline resting systolic and diastolic blood pressure (mm Hg) at 8 weeks
|
|
Change in depression, anxiety and stress scores (0-34) over 8 weeks
Time Frame: Change from baseline DASS-21 score at 8 weeks
|
Depression, Anxiety and Stress Scale Questionnaire (DASS-21, 0-34) to assess depression, anxiety and stress scores from baseline to 8 weeks
|
Change from baseline DASS-21 score at 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 10, 2018
Primary Completion (Actual)
May 3, 2019
Study Completion (Actual)
August 2, 2019
Study Registration Dates
First Submitted
December 10, 2020
First Submitted That Met QC Criteria
October 27, 2021
First Posted (Actual)
November 5, 2021
Study Record Updates
Last Update Posted (Actual)
November 5, 2021
Last Update Submitted That Met QC Criteria
October 27, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Wellness 1
-
Indiana UniversityCommunity Health Network; Boys & Girls Clubs of IndianapolisCompletedMental Health Wellness 1 | Child Behavior | Adolescent Behavior | Mental Health Wellness 2United States
-
Cedars-Sinai Medical CenterNot yet recruitingMental Health Wellness 1 | Wellness, PsychologicalUnited States
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Universiti Putra MalaysiaGreen International UniversityNot yet recruitingMental Health Wellness 1
-
Northern Arizona UniversityUniversity of Colorado, DenverRecruiting
-
The New SchoolColumbia University; Universidad del Norte; HIASRecruitingMental Health Wellness 1Colombia
-
University of Wisconsin, MadisonCompletedMental Health Wellness 1United States
-
University of BathKing's College London; University of Pennsylvania; Newcastle University; University... and other collaboratorsCompletedMental Health Wellness 1United Kingdom
-
The University of Hong KongThe Boys' and Girls' Clubs Association of Hong KongCompleted
-
University of South WalesMIND CymruTerminated
Clinical Trials on Multi-Ingredient Herbal Supplement
-
Northern Illinois UniversityCompletedHealthy Adult MaleUnited States
-
Arizona State UniversityActive, not recruitingQuality of LifeUnited States
-
McMaster UniversityNot yet recruitingObesity | Lysosomal Storage Diseases | Muscle Loss | Glycogen Storage Disease Type II | Pompe Disease | Nutrition Poor | Glycogen Storage Disease Type II, Adult | Glycogen Storage Disease Type II Late Onset
-
Medimix Specialty Pharmacy, LLCSuspended
-
Hamilton Health Sciences CorporationOne FertilityNot yet recruiting
-
University of GreenwichCrown Sport Nutrition; Go Fit SpainCompletedFatigue | Muscular Atrophy | Psychological | Protein Deficiency | Training Group, SensitivityUnited Kingdom
-
University of GreenwichIngesport Health Spa ConsultingNot yet recruitingQuality of Life | Obesity | Stress, Psychological | Self-Perception | Weight Loss | Happiness | Obesity, Abdominal | Muscle LossUnited Kingdom
-
Olly, PBCCompleted
-
University of TaipeiCompletedBody Composition | Athletic Performance | Protein | Whey ProteinTaiwan
-
Academia Sinica, TaiwanNational Health Research Institutes, Taiwan; Miao-Li General Hospital, Miao-Li...Completed